Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
XP13512 is well-tolerated and effective in treating symptoms and improving mood in moderate to severe RLS: Results of a 2-week, randomized, double-blind, placebo-controlled exploratory trial 62nd Annual Meeting of the Society-of-Biological-Psychiatry Tran, P., Kushida, C. A., Becker, P. M., Ellenbogen, A. L., Walters, A. S., Canafax, D. M. ELSEVIER SCIENCE INC. 2007: 238S–238S
View details for Web of Science ID 000245698100762